Invention Grant
- Patent Title: Thermostable type-A DNA polymerase mutant with increased resistance to inhibitors in blood
-
Application No.: US14568549Application Date: 2014-12-12
-
Publication No.: US09758773B2Publication Date: 2017-09-12
- Inventor: Nancy Mckinney , Holly H. Hogrefe , Jeffrey Fox , Connie J. Hansen , Bahram Arezi
- Applicant: Agilent Technologies, Inc.
- Applicant Address: US CA Santa Clara
- Assignee: Agilent Technologies, Inc.
- Current Assignee: Agilent Technologies, Inc.
- Current Assignee Address: US CA Santa Clara
- Main IPC: C12N9/12
- IPC: C12N9/12 ; C12Q1/68
Abstract:
The invention provides mutants of DNA polymerases having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases.
Public/Granted literature
- US20150232821A1 Thermostable Type-A DNA Polymerase Mutant with Increased Resistance to Inhibitors in Blood Public/Granted day:2015-08-20
Information query
